Ronald L. Fischer
Tracked across 1 events · 20 articles · First seen Jul 20, 2026 · Last active Aug 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
GT Biopharma, a United States — Los Angeles-based biopharmaceutical company, terminated its Chief Medical Officer Richard Graydon on July 17, 2026, citing reasons unrelated to his activities at the company. Shortly thereafter, media reports revealed…
Impact: Ronald L. Fischer, also known as Richard Graydon, is the fugitive at the center of the scandal. His arrest and false identity have caused significant harm to Immix's reputation and stock price.
Jul 20, 2026 · 20 articles
90
Ronald L. Fischer operated under false identityImmix Biopharma executive...
ERGEN INTELLIGENCE
Track Ronald L. Fischer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard